key: cord-0504111-sxcfq317
authors: Kline, Adrienne; Wang, Hanyin; Li, Yikuan; Dennis, Saya; Hutch, Meghan; Xu, Zhenxing; Wang, Fei; Cheng, Feixiong; Luo, Yuan
title: Multimodal Machine Learning in Precision Health
date: 2022-04-10
journal: nan
DOI: nan
sha: 2206519925d76b2b60ea652fb9440b5a3bd98664
doc_id: 504111
cord_uid: sxcfq317

As machine learning and artificial intelligence are more frequently being leveraged to tackle problems in the health sector, there has been increased interest in utilizing them in clinical decision-support. This has historically been the case in single modal data such as electronic health record data. Attempts to improve prediction and resemble the multimodal nature of clinical expert decision-making this has been met in the computational field of machine learning by a fusion of disparate data. This review was conducted to summarize this field and identify topics ripe for future research. We conducted this review in accordance with the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) extension for Scoping Reviews to characterize multi-modal data fusion in health. We used a combination of content analysis and literature searches to establish search strings and databases of PubMed, Google Scholar, and IEEEXplore from 2011 to 2021. A final set of 125 articles were included in the analysis. The most common health areas utilizing multi-modal methods were neurology and oncology. However, there exist a wide breadth of current applications. The most common form of information fusion was early fusion. Notably, there was an improvement in predictive performance performing heterogeneous data fusion. Lacking from the papers were clear clinical deployment strategies and pursuit of FDA-approved tools. These findings provide a map of the current literature on multimodal data fusion as applied to health diagnosis/prognosis problems. Multi-modal machine learning, while more robust in its estimations over unimodal methods, has drawbacks in its scalability and the time-consuming nature of information concatenation.

Clinical decision support has long been an aim for those implementing algorithms and machine learning in the health sphere [1] [2] [3] . Examples of algorithmic decision supports utilize lab test values, imaging protocols or clinical (physical exam scores) hallmarks. 4, 5 Some health diagnoses can be made on a single lab and a single threshold. This is the case in diabetes in older adults 6 . Other diagnoses made based on a constellation of the signs, symptoms, lab values and/or supportive imaging are referred to as a 'clinical diagnosis'. Oftentimes these clinical diagnoses are based on additive scoring systems that representing a threshold that requires crossing, or a mixture of positive and negative hallmarks required prior to confirmatory labeling. One example of such a diagnostic protocol is with Parkinson's disease. Two supportive features are required to be included in the diagnosis such as bradykinesia, rigidity, rest tremor or a beneficial response to dopaminergic therapy. Exclusionary criteria for Parkinson's include but is not limited to; a history of repeated strokes with an associated stepwise Parkinsonian manifestation, or severe autonomic failure (e.g. orthostatic hypotension) 7 . This example highlights the expected benefit of leveraging both imaging data (for history of strokes), combined with structured Electronic Health Records (EHR) that provides blood pressure measurements for indicative of orthostatic hypotension and clinical exam findings.

The modus operandi of a clinical diagnosis may fail to consider the importance of relative weighting of these disparate data inputs due to the limitations of human decision-making capacity and potentially non-linear relationships. The strength of algorithmic decisionmaking support is that it can be used to offload such tasks, ideally yielding a more successful result. This phenomenon has sparked an interest in fusion studies using health care data. The purpose of this study is to highlight the current scope of this research domain.

Undertakings to characterize this literature have been performed by Huang et al. 8 , who performed a systematic review of deep learning fusion of imaging and EHR data in health. However, it was limited to EHR and imaging data, where only deep learning applications were shown. In a follow-up paper 9 that included commentary on omics and imaging data fusion. The current study is more inclusive in the breath of the types of machine learning protocols used and attempts to encompass all current modalities.

Data fusion is underpinned by information theory and is the mechanism by which disparate data sources are merged to create an information state based on the sources' complementarity 10 . Data fusion is concisely defined as: ". . . the process of combining data to refine state estimates and predictions." 11 updating the commonly used definition: 'A process dealing with the association, correlation, and combination of data and information from single and multiple sources to achieve refined position and identity estimates, and complete and timely assessments of situations and threats, and their significance.' 12 .

The hope and expectation in machine learning is that doing so will result in an improvement in predictive power 13, 14 and therefore more reliable results in potentially low validity settings 15 .

Data fusion touts the advantage that the results of modeling become inherently more robust, by relying on a multitude of informational factors rather than a single type. However, the methodology of combinatory information has drawbacks; adding complexity to specifying the model and reducing the interpretability of results 15, 16 .

Successful data fusion is built on the pillar of data harmonization, that is quality control of data performed alongside the models in which it will be implemented. Because data from different sources and file formats are rarely uniform, and this holds true especially for clinical data 17 . For example, data sets can have different naming conventions, units of measure, represent different local population biases. This feat can be difficult, and a balance is required between efficacious harmonization (information that is similar and works together) and pure (information that corresponds 1:1) 18 . Care must be taken to search and correct for systematic differences between datasets and assess the degree of interchangeability. For example, Colubri et al. in order to aggregate computed tomography (CT) and PCR labs, they performed an intra-site normalization to ensure that values were comparable across sites and needed to discard several potentially informative clinical variables since they were not available in all datasets 19 . The clinical field of Heart Failure with preserved ejection fraction (HFpEF) saw novel applications of multiple tensor factorization formulations to integrate the deep phenotypic and trans-omic information 20 , and this extends to other areas of precision medicine 21 . To increase the portability of EHR-based phenotype algorithms, the Electronic Medical Records and Genomics (eMERGE) network has adopted common data models (CDMs) and standardized design patterns of the phenotype algorithm logic to integrate EHR data with genomic data and enable generalizability and scalability [22] [23] [24] [25] .

Given the recency of this literature, there is no consensus on the optimal way to combine data. Classification of informational source amalgamation was first posed by Durrant-Whyte 26 . Incoming data can be complementary; where sources represent different aspects of the entity under investigation, redundant; where sources provide the same information and serve to reinforce the information, and lastly cooperative; where the information is fused to create new information of a higher order. It is this last class or cooperative information that data fusion takes its roots.

There are three main types of data fusion that are used in machine learning; early (data-level), intermediate (joint), and late (decision-level) 27 . In the case of early fusion, multiple data sources are converted to the same information space. This often results in vectorization or numerical conversion from an alternative state, as performed by Chen et al. via vectorized pathology reports 28 . Images possess characteristics that can undergo numerical conversion based on area, volume, and/or structural calculations 29 . These are then concatenated with additional measurements from structured data sources and fed into an individual classifier. Canonical correlation analysis 30 , non-negative matrix factorization 31, 32 , Independent Component Analysis (ICA) and numerical feature conversion methodologies exist as common options to transform all data into the same feature space 33 .

Intermediate data fusion occurs inside a step-wise set of models and offers the greatest latitude in model architecture. A 3-stage deep neural learning and fusion model was proposed by Zhou et al. 34 where stage 1 consists of feature selection by a soft-max classifier for independent modalities. Stage 2 and 3 constitute combining these selected features, establishing a further refined set of features, and feeding these into a Cox-nnet to perform joint latent feature representation for Alzheimer's diagnosis. In contrast to early fusion, intermediate fusion combines the features that distinguish each type of data to produce a new representation that is more expressive than the separate representations from which it arose.

In late fusion, multiple models are trained, where each model corresponds to an incoming data source. This is akin to ensemble learning, which offer better performance over individual models 35 . Ensemble methods use multiple learning algorithms (typically applied to the same dataset) to obtain better predictive performance than could be obtained from any of the constituent learning algorithms alone. However, in the case of multimodal ML ensemble here can refer to ensemble learning within a data type and across data types. Common ensemble learning methods include bagging, boosting, stacking, random forest, and Bayesian optimal classifier. These takes symbolic representations as sources and combine them to obtain a more accurate decision 36 . Bayesian's methods are typically employed at this level 26 to support a voting process between the set of models into a global decision. A broad-based schematic for the 3 subtypes of data fusion are presented in Figure 1 .

Early and late fusion have the greatest flexibility as to the number of models that can be fused. Early fusion gains this advantage by converting all data into the same feature space that can be classified using simpler models such as support-vector machines or logistic regression. While there inevitably exists a loss of information via dimensionality reduction using this method, it involves a single model and therefore offers a propitious entry point for those wishing to perform fusion for health predictions. Attribute differences and similarities are showcased in Table 1 . 

There are several research questions that drove this review: RQ1-What characterizes the published literature using multimodal data fusion in the health sector? A multiplicity of different lenses will be used to showcase these studies.

In addition to providing a summary of the analytical techniques applied, this RQ aims to explore the challenges and opportunities that researchers have encountered in implementing these techniques.

This RQ aims to identify current gaps in the literature that will provide recommendations for future information concatenation in the health sector. Also, how the results of this RQ allow different health care researchers the opportunity to make informed decisions on how to use multi-modal data fusion as part of their studies.

Inclusion requirements are: an original research article published within the last 10 years which inclusively encompassed years 2011-2021, published in English and on the topic of multi-modal or multi-view using machine learning in health for diagnostic or prognostication applications. 'multi-modal' or 'multi-view' for our context and sake of brevity is taken to mean data sources not of the same type. For example, a paper using CT and MRI would be considered multi-modal imaging but under our premise was considered to be uni-modal i.e. imaging. Exclusions for these purposes of this review were scientific articles not published in English, commentaries or editorials, other review articles. Papers were also excluded if the data was not human derived. We also excluded papers where the fusion already occurred at the data generation stage, such as spatial transcriptomics producing integrated tissue imaging and transcriptomics data [37] [38] [39] . All papers underwent a 2-person verification for inclusion in the manuscript.

Search strings were established via literature searches, domain expertise. Additional keywords were identified based on key word co-occurrence matrices established from the abstracts of the previous articles found. Table 2 displays the search strings, where an individual string would include one keyword from each column. For example, "health + heterogeneous data + machine learning" would be one of the search strings for automatic search. This process was repeated until all combinations of search strings were incorporated. An overview of the inclusion/exclusion process is noted in Figure 2 and echoes the standard set by PRISMA extension for scoping reviews 40 . All titles included in this review can be seen in Supplementary material. Table 2 . health-related keyword, Multimodal-related keyword, machine learning-related keywords, | : or

Information garnered from the articles included title, year published, FDA approval of the tool, whether published in a clinical journal, author affiliations, number of authors, locations (continents) and abstract. Health context information extracted included the specific health disease under investigation and the healthcare domain(s) that this fall under. It should be noted that several topics fell into one or more broad based health topics. For example, the specific health care topic might be small-cell lung cancer. The corresponding health care domains would be respiratory and cancer.

Given the multi-modality aspect of machine learning, we also recorded and extracted the number of different modalities used and the divisions (i.e. text/image vs EHR/genomic/time series). To elucidate this, a paper characterized using lab values (structured EHR) and computed tomography as input into machine learning would be categorized as 'Imaging/EHR' subtype. The objective of each paper was extracted in a 1-2 sentence summary along with the keyword (if available). Patient characterization in the studies noted was performed by ascertaining the number of unique patients leveraged in the cohort and patient sex (i.e. Men/women/both or not mentioned).

Computational information extracted via recording the coding interface(s) used in data processing/analysis, machine learning type, data merging technique (early, intermediate, late) and types of machine learning algorithms used. Validation of the results of any machine learning work is important. Statistical tests run, whether validation was performed (yes/no) and the nature of that validation and other outcomes measures were all recorded for each paper. Validation consisted of leave-one-out cross validation, train-test split, n-fold cross validation. Statistical tests comparing outcomes from varying models included but were not limited to: student's t-test, Chi-square, ANOVA etc. Outcome measures included accuracy, F1, recall, sensitivity, specificity etc. Assessing the significance, impact and limitations of each paper was extracted by noting their primary findings and individual limitations as noted in the papers.

The topic modelling displayed in Figure 3 showcases the category, specific health ailment under investigation and the modality type. Neurology and singularly Alzheimer's had the most papers published on this topic, accounting for 22 of the publications 33, 41 . Individual health diseases/diagnoses are mapped to all applicable overarching health topic areas as noted previously in the data extraction section above. With the advent of the COVID-19 pandemic, several primary research articles are dedicated (5) [42] [43] [44] [45] [46] , which can be arrived at through respiratory or infectious disease hierarchies. Articles are subsequently mapped back to their multi-modal subtype on the right of the Sankey plot.

This should serve as a resource to fellow researchers to identify areas that lack such saturation, namely dermatology 47 , hematology 48 , medication/drug issues such as alcohol use disorder investigated by Kinreich et al. that may offer new research horizons 49 . A dashboard resource published in conjunction with this review article is available here https://multimodal-mlhealth.herokuapp.com/. This dashboard was created as an interactive infographic-based display of some major findings presented here. To assist and spawn future work, a drop-down menu has been created to help researchers filter our underlying data file of titles based on overarching health topic by selection, so they may more readily find and read the papers as presented whose broader trends are presented here.

Of the models used in the papers, 128/130 explicitly reported performing a validation procedure of their model(s). The most common validation performed were; N-fold cross validation (54) 50,51 , train test split (55) , leave one out cross validation (9) and external dataset (10) . A cornucopia of machine learning techniques and methods were comprised both within and across articles in this review. They have been summarized in Table 3 noting which fusion umbrella subtype they were implemented in. 

All papers noted in this review used either two or three disparate data sources when fusing their data. Fusing two data sources, and specifically that of imaging and EHR (n=52) was the most prevalent as per Table 4 . Figure 4 A showcases the relative distributions of preferred interface type and fusion strategy, the most popular being the Python platform and early fusion. 70 papers were published using early fusion. Of those, most were published using imaging and EHR data 31, 33, 46, 47, 52, 55, 56, 59, [61] [62] [63] 67, 70, 72, 74, [84] [85] [86] [87] [89] [90] [91] [92] 94, 100, 106, 107, 110 . Nearly all these papers performed numericalization of their images prior to processing, however two performed matrix factorization 31, 33 .

A combination of EHR and text data was noted in 12 papers 28 164 . Their best performing model was one that implemented instance-based explanations of the random forest classifier by using the SHapley Additive exPlanations (SHAP) feature attribution. Despite using clinical, genomic and imaging data, the most influential feature was found to be the Mini-Mental State Examination.

Both men and women were represented relatively equally across papers, however varied in that distribution within an individual studies. Data fusion may help address sex differences and increase population diversity issues (including minority population) in health modeling by creating a more cohesive representative dataset if one datatype contained more of one and the reciprocal true for the other datatype(s). This would also hold true for racial or ethnic diversities. Less than half (37.6%) of the papers were published in a journal intended for a clinical audience. However, none of the papers included in the final cohort of studies had created tools for clinical use that had FDA approval. Figure 4 B contains the breakdown of total number of publications in this field over the last 10 years, and the Figure 4 C continental contributions of authors. Asia and North America had a near equal number of publications 60 and 61 respectively. Note that some titles had repeated counts due to cross-continent collaborations between authors.

Returning to our research questions, we outlined from the inception of this work:

The literature published in this area as displayed and characterized in the results' section is one that has a growing and global interest. It is fueled by a desire to improve predictive capabilities, relying on complimentary and correlative (reinforcing) data. The most common health topic was Neurology, and the second most was cancer. The relative saturation of this field likely reflects the underlying multimodal diagnosis that is present in a clinical counterpart i.e. neuroimaging and EHR (cognitive scores) as well as the number of established and curated databases that lends itself well for multi-modality predictions such as Alzheimer's Disease Neuroimaging Initiative 165 and The Cancer Genome Atlas Program 166 . Early data fusion methods leveraging imaging and EHR data likely owe their pervasiveness for reasons that are three-fold; 2 modalities over 3 is means less work overall in model building and deployment, EHR and image data do not require as extensive digital conversion for models such as text, and lastly early fusion is built on a single model with a multitude of feature inputs and is typically less computationally complex. Only 4 articles performed comparisons against their human clinician counterparts. Several did perform comparisons between uni-modal and multi-modal predictions, with the majority of those citing an improvement from baseline by incorporating heterogeneous data types. Of the studies that compared predictive performance between multi-modal data and uni-have modal data, there is a consistent citing of improvement in classification accuracy, sensitivity, and specificity. However, this was not seemingly limited to a particular subtype of multi-modal strategy that was detectable in our metadata. We therefore make the overall and general recommendation that multi-modal data integration be attempted to improve performance and better mirror a human expert by creating a higher validity environment from which to make clinical decisions.

The analysis techniques are varied and currently do not showcase a gold standard or 'bestpractice' in the field. This is likely linked to this being a relatively new and emerging field. Further, while an N-cross fold validation was the most common and a robust estimator in the face of bias within a dataset, strength of generalizability stems from either the dataset set containing multi-site/location patient data to begin with or using an external dataset from a remote location 167 .

Health contexts predominantly impacted by this include Neurology and Cancer predictive modeling, though no domain laid claim to building translation models via FDA (or equivalent) approval for use in clinical circumstances. As multi-modal fusion is touted to be an important fulcrum from which to leverage disparate types of information, there are calls to compare models more readily to physician decision makers [168] [169] [170] [171] . This will guide the validity of the environments suitable to machine learning/artificial intelligence decision makers and hopefully result in the adoption and therefore FDA approval of these tools. In the review performed by Lyell et al. 172 they outline the methods of clinical decision support (assistive, autonomous information and autonomous decision), and acknowledge FDA approval of ML devices is a recent development.

For without deployment, the benefits to these exercises remain minimal and indirect. Information fusion has led to an increase in predictive performances over single modalities 52, 111, 163 .

The most common reported limitations in the papers included in the review are: 1) Cohort built on a single site/location: Samples were most often built from a single hospital or academic medical center 153 . A corollary of this issue is that most studies were based on samples from a single country. Because of the lack of an external cohort, it was difficult to validate and generalize the proposed model across different health systems.

2) Small Sample size: The median number of unique patients reported across the studies was 658 with a standard deviation of, 42600. This suggests that while some studies were able to leverage large and multi-center cohorts, a great many were not able to. Sample size were usually too small to train the model completely and obtain the best performance 69, 81, 120, 125 .

3) Retrospective data: Are Seldom machine learning investigations performed prospectively, this is endemic to the machine learning field in general 83 . 4) Imbalanced samples: The imbalance problem in terms of positive and negative samples was usually ignored, which biases the model and is unfair to the validation test samples 74, 150 . It is necessary to address the imbalance problem by adopting techniques such as under-or oversampling or differential weighting for training samples. 5) Handling of missing data: Missing data were usually ignored by dropping data points or imputing. It is very important to address this issue, if not dealt with appropriately can skew the results due to a biased model 67, 109, 173 . More studies need to discuss frequencies and types of missing data, and the imputation method used, if any, to create a full data set [174] [175] [176] [177] . Comparison of different imputation methods on the final results should be part of the reporting process 178 . 6) Feature engineering: Extracting features completely are important to the predictive or classification model. The features extracted based on feature engineering may not be enough for training models, which is usually time-consuming and dependent on empirical knowledge from experts 110 . Deep learning-based techniques have been considered by researchers in some previous studies to extract features automatically from a dataset. 7) Confounding factors: When performing statistical analysis, researchers usually ignored possible confounding factors such as age or gender, which may have major effects on the impact of results 42 . Such possible confounding effects should either be taken into consideration by the model 179, 180 or adjusted first, prior to reporting model results. 8) Interpretation: Reasonable interpretations of the model and outputs must be presented so that clinicians find the results credible and then use them to provide guidance for treatments. However, most authors did not take the time to interpret the models for clinical audiences, and how the results provide useful tools. Different types of models need different types of explanation 41, 123 . For example, using explainable tools such as Local Interpretation Model-Agnostic and Shapely Additive Explanation would clarify such feature contributions. Limitations are highlighted 'where' in the data processing and modeling building pipeline they exist, as per Figure 5 .

To expedite and facilitate this field, we have outlined a number of gaps for future researchers in this field that we have garnered having performed this review. These are listed below, with specific suggestions.

The relative topic saturation showcased in Figure 3 above has highlighted notable places for future work. Two subdivisions that become apparent are; 1) several topics that would benefit from more work in that area, and 2) the need to progress health topics where significant effort has already been made. Medication/drug topics present an underrepresented area, with only two papers being published in this field 49, 65 . Given current issues with drug interaction effects and recommendation guidelines such as the Beer's criteria 181 for use in older patients, performing multimodal machine learning may offer an earlier detection of medication misuse that is marked by iatrogenic error, user non-compliance or addiction.

Multimodal investigation may be a key to unlocking early detection, given the manifestations of misuse may be reflected in structured data (EHR) or imaging data. Take, for example, a heart failure patient who has inadvertently taken or been prescribed the wrong dosage of their diuretic 109 . Here this could be reflected in lab values (urine and serum) and systemic opacity on chest x-ray. The opioid crisis is wreaking havoc on the medical system, two hallmarks of which include pinpoint pupils and depressed respiratory status 182 . This also represents an area where image assessment of pupillary status and assessment of vitals (structured) may assist in making the decision to provide naloxone. Awareness of drug interaction effects is a difficult and growing issue [183] [184] [185] [186] , particularly in geriatrics, which gave rise to Beer's criteria. However, this does little to assess real time adverse events and may present another avenue of lucrative health returns if modeled with multimodal machine learning.

Yap et al. published the only dermatology geared paper contained in this review 47 . While some dermatological conditions are self-contained to the skin, many can be linked to gastrointestinal disease, infections or systemic cancer. Digital images of dermatological manifestations combined with lab values and clinical impressions via unstructured text presents a gateway of novel research questions. Therefore, the gauntlet has been thrown for pursuing a multimodal line of inquiry and exploration that could have both diagnostic and potentially screening implications in primary care settings. Similar justifications as outlined above could be applied to other areas seen as 'lacking' such as hematology with 1 paper 48 and nephrology having 3 86, 108, 112 .

Conversely, the topics with more corresponding papers may improve their application and cement their gained expertise in our subsequent suggestions.

A multitude and extensive methodological undertaking is evident, characterized in the titles included in our review. While incorporating disparate data does lend itself to seemingly better predictions 142 , our knowledge around certain diseases continue to accumulate and new data modalities continue to emerge. Thus, data fusion in healthcare is an evolving target that calls for machine learning framework to proactively adapt to the dynamic landscape 187 .

It is anticipated this will vary based on the diagnosis or prognosis under investigation. For example, it has been shown in protein-protein interactions that utilization of the XGBoost algorithm reduces noisy features, maintain the significant raw features, and prevent overfitting via average gain 122 . XGBoost is a gradient boosting decision tree using regularized learning and cache-aware block structure tree learning for ensemble learning. The average gain is the total gain of all trees divided by the total number of splits for each feature. The higher the feature importance score of XGBoost is, the more important and effective the corresponding feature is 122 . Similarly, LightGBM is an ensemble algorithm developed by Microsoft that provides an efficient implementation of the gradient boosting algorithm 188 . LightGBM has the advantages of faster training speed, higher efficiency, lower memory usage, better accuracy, being capability for handling large-scale data, and the support of parallel and GPU learning 189 , and has been consistently outperforming other models 190, 191 . This represents a possible avenue for the advent of information fusion from disparate data in healthcare.

Augmenting clinical decision-making with ML to improve clinical research and outcomes present positive impacts that have economic, ethical, and moral ramifications as it has the ability to reduce suffering and save human lives. Multiple studies have pointed to that bias of the underlying data often lead to the bias in the resulting ML models 192, 193 . The ethical imperative now on offer requires overcoming several hurdles with respect to data structure and federated access, clear definition of outcomes, assessment of biases and interpretability/transparency of results and limitations inherent in its predictions 194 . Future work is subsequently invited on a perdisease basis to characterize the combinatorics (which fusion strategy and set of mixed data types) optimize model performance. Doing so will push individual fields to create recommendations for subsequent real-world implementations.

Continuing in the same vein, model optimization with respect to disease-based predictions is the ease of use when modeling the data and the ensuing interpretability to end users. The extensive prepossessing and transformation inherent in multimodal machine learning create a significant and systemic drawback to its use. Perotte et al. 108 Trade-offs between increasing accuracy at the expense of complex and time-consuming data transformations may mean the predictive power gained from a multimodal approach is offset by this front-end bottleneck and may mean predictions are no longer temporally relevant or useful. In addition to knowing how the models should be built per disease, we also advocate for pipelines and libraries to speed up data conversion processes via open access to make the technology more widely available 195, 196 .

Going from bench to bedside should be the goal of machine learning in medicine. Otherwise, these become technical exercises without real world impact. While lacking in the reviewed literature, it is understandable given the infancy of the machine learning health data fusion field. As machine learning and multimodal ML become more ubiquitous, there are increased demands for regulation and accountability.

Of crucial importance for uptake is that predictions be patient specific and actionable at a granular level 197 198 , while efforts to vie for Food and drug administration (FDA) approvals as a tool for use are encouraged to increased adoption.

Limitations of this work include that it is not a systematic review. Therefore, it is possible that some titles that should have been included were missed. However, to mitigate this issue search strings were included based on both empirical knowledge in the field and alternative synonyms and keywords were identified using a literature review and language modelling and lexical analysis to find the context-sensitive terms that present the field. This was performed by using keyword co-occurrence strategy on each paper's objectives within the abstract of the article. As the primary purpose of this study was to perform scientific paper profiling on multimodal machine learning in health, a critical appraisal of individual methodological quality of the included studies was not performed. However, commentary is provided on the methodological limitations that could have affected their results and impact.

To our knowledge, this is the first review that offers a comprehensive meta-analysis evaluation across health domains, immaterial to the type of machine learning or the data used. This work serves as both a summary and steppingstone for future research in this field. The topic areas of health that have saturation relative to others were highlighted, which serves to build a foundation for future work. FDA approval and design of the tools for clinical centers also remains a large and outstanding invitation for further research to continue. Multi-site data integration is of the utmost importance for creating models that are generalizable and representative of the populace at large. Comparing developed models against working clinician counterparts would go a long way to effecting meaningful change in the uptake of algorithm-based decision-making models. Unimodal machine learning is inherently in contrast to current routine clinical practice in which imaging, clinical or genomic data are interpreted in unison to inform accurate diagnosis and warrants further work for ease of use and implementation. Overall, it appears justified to claim that multi-modal data fusion increases predictive performance over uni-modal approaches and is warranted where applicable and available results provide tenable models.

AK lead the review process, performed data extraction, performed the computation analysis, figure generation, writing and dashboard creation. HW, YL, SD, MH performed data extraction. ZX synthesized limitations of the studies. FW and FC performed proof reading and content curation. YL conceived the review, oversaw the review process and provided necessary feedback, proof reading, and content curation.

We declare no competing interests.

The ethics of machine learning-based clinical decision support: an analysis through the lens of professionalisation theory

Big Data and Data Science in Critical Care

Deep learning for healthcare: review, opportunities and challenges

Machine learning of threedimensional right ventricular motion enables outcome prediction in pulmonary hypertension: A cardiac MR imaging study

Predicting breast cancer risk using personal health data and machine learning models

Clinical and public health implications of 2019 endocrine society guidelines for diagnosis of diabetes in older adults

MDS clinical diagnostic criteria for Parkinson's disease

Fusion of medical imaging and electronic health records using deep learning: a systematic review and implementation guidelines

A review of fusion methods for omics and imaging data

A review of data fusion techniques

Revisions to the JDL data fusion model

Improved accuracy in predicting the best sensor fusion architecture for multiple domains

Advances in Machine Learning Approaches to Heart Failure with Preserved Ejection Fraction

Machine Learning/Artificial Intelligence for Sensor Data Fusion-Opportunities and Challenges

Machine Learning Applications in Diagnosis, Treatment and Prognosis of Lung Cancer

What every reader should know about studies using electronic health record data but may be afraid to ask

Machine-learning-based patient-specific prediction models for knee osteoarthritis

Machine-learning Prognostic Models from the 2014-16 Ebola Outbreak: Data-harmonization Challenges, Validation Strategies, and mHealth Applications

Tensor factorization for precision medicine in heart failure with preserved ejection fraction

Tensor factorization toward precision medicine

Considerations for Improving the Portability of Electronic Health Record-Based Phenotype Algorithms

Characterizing design patterns of EHR-driven phenotype extraction algorithms

Solutions for Unexpected Challenges Encountered when Integrating Research Genomics Results into the EHR

Making work visible for electronic phenotype implementation: Lessons learned from the eMERGE network

Sensor models and multisensor integration

Multimodal Data Fusion: An Overview of Methods, Challenges, and Prospects

The utility of including pathology reports in improving the computational identification of patients

Prediction and Classification of Alzheimer's Disease Based on Combined Features From Apolipoprotein-E Genotype, Cerebrospinal Fluid, MR, and FDG-PET Imaging Biomarkers

Multimodal Data Analysis of Alzheimer's Disease Based on Clustering Evolutionary Random Forest

Non-negative matrix factorization of multimodal MRI, fMRI and phenotypic data reveals differential changes in default mode subnetworks in ADHD

Recent advances in supervised dimension reduction: A survey. Machine learning and knowledge extraction

Fusing Heterogeneous Data for Alzheimer's Disease Classification

Effective feature learning and fusion of multimodality data using stage-wise deep neural network for dementia diagnosis

Ensemble based systems in decision making

Multimodal temporal machine learning for Bipolar Disorder and Depression Recognition. Pattern Analysis and Applications

Method of the Year: spatially resolved transcriptomics

Statistical and machine learning methods for spatially resolved transcriptomics data analysis

Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics

Multimodal deep learning models for early detection of Alzheimer's disease stage

On the application of advanced machine learning methods to analyze enhanced, multimodal data from persons infected with covid-19

Accurately Differentiating COVID-19, Other Viral Infection, and Healthy Individuals Using Multimodal Features via Late Fusion Learning

A cognitive IoT-based framework for effective diagnosis of COVID-19 using multimodal data

An intelligent multimodal medical diagnosis system based on patients' medical questions and structured symptoms for telemedicine

Multimodal skin lesion classification using deep learning

A machine learning approach to predict and validate MicroRNA-disease associations by integrating of heterogenous information sources

Predicting risk for Alcohol Use Disorder using longitudinal data with multimodal biomarkers and family history: a machine learning study

MRI predictors of amyloid pathology: Results from the EMIF-AD Multimodal Biomarker Discovery study

Radiogenomics predicts the expression of microRNA-1246 in the serum of esophageal cancer patients

Enhancing image analytic tools by fusing quantitative physiological values with image features

Methodological Issues in Predicting Pediatric Epilepsy Surgery Candidates through Natural Language Processing and Machine Learning

Predicting Alzheimer's Disease Conversion From Mild Cognitive Impairment Using an Extreme Learning Machine-Based Grading Method With Multimodal Data

Predicting rehospitalization within 2 years of initial patient admission for a major depressive episode: a multimodal machine learning approach

Identification of Alzheimer's disease and mild cognitive impairment using multimodal sparse hierarchical extreme learning machine

Wearable monitoring and interpretable machine learning can objectively track progression in patients during cardiac rehabilitation

Robust hybrid deep learning models for Alzheimer's progression detection. Knowledge-Based Systems

Machine learning-based prediction of clinical pain using multimodal neuroimaging and autonomic metrics

An Efficient Combination among sMRI, CSF, Cognitive Score, and APOE ϵ 4 Biomarkers for Classification of AD and MCI Using Extreme Learning Machine

Multimodal manifoldregularized transfer learning for MCI conversion prediction

Separating generalized anxiety disorder from major depression using clinical, hormonal, and structural MRI data: A multimodal machine learning study

Multiple kernel learning in the primal for multimodal alzheimer's disease classification

Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of

Predicting adverse drug reactions of combined medication from heterogeneous pharmacologic databases

Toward differential diagnosis of autism spectrum disorder using multimodal behavior descriptors and executive functions

Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: A machine learning approach Retina

Early identification of epilepsy surgery candidates: A multicenter, machine learning study

Detecting Risk Gene and Pathogenic Brain Region in EMCI Using a Novel GERF Algorithm Based on Brain Imaging and Genetic Data

High-Accuracy Detection of Early Parkinson's Disease through Multimodal Features and Machine Learning

Machine Learning for Localizing Epileptogenic-Zone in the Temporal Lobe: Quantifying the Value of Multimodal Clinical-Semiology and Imaging Concordance

Assessment of liver fibrosis in chronic hepatitis B via multimodal data

Multimodal tensor-based method for integrative and continuous patient monitoring during postoperative cardiac care

Predictive big data analytics: A study of Parkinson's disease using large, complex, heterogeneous, incongruent, multi-source and incomplete observations

Deep radiotranscriptomics of nonsmall cell lung carcinoma for assessing molecular and histology subtypes with a data-driven analysis

Identifying disease sensitive and quantitative trait-relevant biomarkers from multidimensional heterogeneous imaging genetics data via sparse multimodal multitask learning

A novel CERNNE approach for predicting Parkinson's Disease-associated genes and brain regions based on multimodal imaging genetics data

Predicting Complications in Critical Care Using Heterogeneous Clinical Data

Prediction of breast cancer distant recurrence using natural language processing and knowledge-guided convolutional neural network

Identifying Breast Cancer Distant Recurrences from Electronic Health Records Using Machine Learning

Machine learning classification of ADHD and HC by multimodal serotonergic data

Distinct multivariate brain morphological patterns and their added predictive value with cognitive and polygenic risk scores in mental disorders

Radiogenomic analysis of hypoxia pathway is predictive of overall survival in

Combining multimodal imaging and treatment features improves machine learning-based prognostic assessment in patients with glioblastoma multiforme

Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low-and high-grade gliomas

Predicting acute kidney injury in cancer patients using heterogeneous and irregular data

Ensemble-based regression analysis of multimodal medical data for osteopenia diagnosis

Defining a multimodal signature of remote sports concussions

Preoperative risk stratification in endometrial cancer (ENDORISK) by a Bayesian network model: A development and validation study

Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection

Alzheimer's disease risk assessment using large-scale machine learning methods

Multimodal Predictive Modeling of Endovascular Treatment Outcome for Acute Ischemic Stroke Using Machine-Learning

Multimodal Machine Learning-based Knee Osteoarthritis Progression Prediction from Plain Radiographs and Clinical Data

Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test

Explainable Dynamic Multimodal Variational Autoencoder for the Prediction of Patients with Suspected Central Precocious Puberty

RAIM: Recurrent attentive and intensive model of multimodal patient monitoring data

Multimodal fusion of imaging and genomics for lung cancer recurrence prediction

Bidirectional Representation Learning from Transformers Using Multimodal Electronic Health Record Data to Predict Depression

A Comparison of Pre-trained Vision-and-Language Models for Multimodal Representation Learning across Medical Images and Reports

Richer fusion network for breast cancer classification based on multimodal data

Mixed Pooling Multi-View Attention Autoencoder for Representation Learning in Healthcare

Recurrent convolutional neural network based multimodal disease risk prediction

Artificial intelligence-enabled fully automated detection of cardiac amyloidosis using electrocardiograms and echocardiograms

Learning Representations of Medical Concepts with Meta-Embeddings. HEALTHINF; 2020; 2020

An unsupervised learning approach to identify novel signatures of health and disease from multimodal data

Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data

Combining heterogeneous data sources for neuroimaging based diagnosis: re-weighting and selecting what is important

Risk prediction for chronic kidney disease progression using heterogeneous electronic health record data and time series analysis

A machine learning model to predict the risk of 30-day readmissions in patients with heart failure: A retrospective analysis of electronic medical records data

Mixture Model Framework for Traumatic Brain Injury Prognosis Using Heterogeneous Clinical and Outcome Data

Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-smallcell lung cancer

Identification of Predictive Sub-Phenotypes of Acute Kidney Injury using Structured and Unstructured Electronic Health Record Data with Memory Networks

Predicting MCI status from multimodal language data using cascaded classifiers

Multimodal mental health analysis in social media

Predicting mortality in critically ill patients with diabetes using machine learning and clinical notes

Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer

Multimodal Assessment of Parkinson's Disease: A Deep Learning Approach

Radiogenomics model for overall survival prediction of glioblastoma

Deep-Learning Radiomics for Discrimination Conversion of Alzheimer's Disease in Patients With Mild Cognitive Impairment: A Study Based on 18F-FDG PET Imaging

Exploring characteristic features of attention-deficit/hyperactivity disorder: findings from multi-modal MRI and candidate genetic data

Early Prediction of Mortality in Critical Care Setting in Sepsis Patients Using Structured Features and Unstructured Clinical Notes

Improving protein-protein interactions prediction accuracy using XGBoost feature selection and stacked ensemble classifier

Computer-aided diagnosis of hepatocellular carcinoma fusing imaging and structured health data

Feng Qiang X. Multimodal temporal-clinical note network for mortality prediction

Bimodal learning via trilogy of skipconnection deep networks for diabetic retinopathy risk progression identification

Combining structured and unstructured data for predictive models: a deep learning approach

Prediction of Type II Diabetes Onset with Computed Tomography and Electronic Medical Records

TieNet: Text-Image Embedding Network for Common Thorax Disease Classification and Reporting in Chest X-Rays

Distilling Knowledge from Medical Images Using Diagnostic Reports as Optional Semantic References

Multimodal multitask deep learning model for Alzheimer's disease progression detection based on time series data

Integration of Multimodal Data for Breast Cancer Classification Using a Hybrid Deep Learning Method. Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and

Improving clinical outcome predictions using convolution over medical entities with multimodal learning

A Deep Automated Skeletal Bone Age Assessment Model with Heterogeneous Features Learning

An Explainable Multimodal Neural Network Architecture for Predicting Epilepsy Comorbidities Based on Administrative Claims Data

Multimodal fusion strategies for outcome prediction in Stroke

Multitask Representation Learning for Multimodal Estimation of Depression Level

A distributed multitask multimodal approach for the prediction of Alzheimer's disease in a longitudinal study

Modeling longitudinal imaging biomarkers with parametric Bayesian multi-task learning

Learning probabilistic phenotypes from heterogeneous EHR data

Integrating Hypertension Phenotype and Genotype with Hybrid Non-negative Matrix Factorization

Heterogeneity and Classification of Recent Onset Psychosis and Depression: A Multimodal Machine Learning Approach

Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or with Recent-Onset Depression: A Multimodal, Multisite Machine Learning Analysis

A Multimodal Deep Neural Network for Human Breast Cancer Prognosis Prediction by Integrating Multi-Dimensional Data

A machine-learning framework for robust and reliable prediction of short-and long-term treatment response in initially antipsychotic-naïve schizophrenia patients based on multimodal neuropsychiatric data

Early Prediction of Acute Kidney Injury in Critical Care Setting Using Clinical Notes and Structured Multivariate Physiological Measurements

A Predictive Model for Parkinson's Disease Reveals Candidate Gene Sets for Progression Subtype

Disease Prediction by Machine Learning over Big Data from Healthcare Communities

Multimodal spatiotemporal deep learning approach for neonatal postoperative pain assessment

Multimodal Machine Learning Using Visual Fields and Peripapillary Circular OCT Scans in Detection of Glaucomatous Optic Neuropathy

Auxiliary diagnosis of heterogeneous data of Parkinson's disease based on improved convolution neural network

Accessory pathway analysis using a multimodal deep learning model

Multimodal Machine Learning for Automated ICD Coding

A radiogenomics signature for predicting the clinical outcome of bladder urothelial carcinoma

Yu Ping W. A kernel machine method for detecting higher order interactions in multimodal datasets: Application to schizophrenia

Multi-dimensional predictions of psychotic symptoms via machine learning

Deep Learning Based Multimodal Progression Modeling for Alzheimer's Disease

A multidimensional precision medicine approach identifies an autism subtype characterized by dyslipidemia

Clinical text classification with rule-based features and knowledge-guided convolutional neural networks

Using clinical Natural Language Processing for health outcomes research: Overview and actionable suggestions for future advances

Bridging semantics and syntax with graph algorithmsstate-of-the-art of extracting biomedical relations

Natural Language Processing for EHR-Based Computational Phenotyping

Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients with Clinical High-Risk Syndromes and Recent-Onset Depression

Multimodal fusion with deep neural networks for leveraging CT imaging and electronic health record: a case-study in pulmonary embolism detection

Kyung Sup K. A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease

Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization

The cancer genome atlas pan-cancer analysis project

Key challenges for delivering clinical impact with artificial intelligence

Results of the 2016 International Skin Imaging Collaboration International Symposium on Biomedical Imaging challenge: Comparison of the accuracy of computer algorithms to dermatologists for the diagnosis of melanoma from dermoscopic images

Medical applications of NDT data fusion

Unbox the black-box for the medical explainable AI via multi-modal and multi-centre data fusion: A mini-review, two showcases and beyond

Radiological images and machine learning: Trends, perspectives, and prospects

How machine learning is embedded to support clinician decision making: An analysis of FDA-approved medical devices

Using Machine Learning to Predict Laboratory Test Results

A Survey on Missing Values Handling Methods for

3D-MICE: integration of cross-sectional and longitudinal imputation for multi-analyte longitudinal clinical data

Mixture-based Multiple Imputation Model for Clinical Data with a Temporal Dimension

Bidirectional recurrent imputation for time series

Evaluating the state of the art in missing data imputation for clinical data

Training confounder-free deep learning models for medical applications

ScanMap: Supervised Confounding Aware Non-negative Matrix Factorization for Polygenic Risk Modeling

American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

Opioid errors in inpatient palliative care services: A retrospective review

Pharmacovigilance from electronic medical records to report adverse events

Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review

Semeval-2013 task 9: Extraction of drugdrug interactions from biomedical texts

Data mining for potential adverse drug-drug interactions

Proactive vs Reactive Machine Learning in Health Care: Lessons From the COVID-19 Pandemic

LightGBM: A Highly Efficient Gradient Boosting Decision Tree

Diagnosis of diabetes mellitus using gradient boosting machine (Lightgbm)

A novel cryptocurrency price trend forecasting model based on LightGBM

SwiftIDS: Real-time intrusion detection system based on LightGBM and parallel intrusion detection mechanism

Dissecting racial bias in an algorithm used to manage the health of populations

Using Machine Learning to Integrate Sociobehavioral Factors in Predicting Cardiovascular-Related Mortality Risk

The role of machine learning in clinical research: transforming the future of evidence generation

Open source software in industry

Why develop open-source software? The role of non-pecuniary benefits, monetary rewards, and open-source licence type

Artificial intelligence and machine learning in clinical development: a translational perspective

Interpretability of Machine Learning Solutions in Public Healthcare: The CRISP-ML Approach

The study is supported in part by NIH GrantsU01TR003528 and R01LM013337.